Clinical Trial Update: Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating intravitreal faricimab injections or fluocinolone acetonide implants versus observation to prevent vision loss in patients with ra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Retinopathy

Drugs mentioned

• ILUVIEN (fluocinolone acetonide)
• VABYSMO (faricimab)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Radiation Retinopathy, Visual Impairment | Phase 3 | Status: RECRUITING